Press Release Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 10
Press Release Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner Jul 9
Press Release Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy Jul 7